FDA Alerts Health Care Providers to Cases of Neurologic Complications from General Anesthesia Linked

FDA Alerts Health Care Providers to Cases of Neurologic Complications from General Anesthesia Linked to Genetic Variant in Patients of Maternal Venezuelan Ancestry

The U.S. Food and Drug Administration (FDA) is investigating the safety of sevoflurane and other general anesthetics based on published scientific reports of unexpected catastrophic outcomes, including severe neurologic adverse outcomes and death, occurring in adult and pediatric patients.

http://www.fda.gov/drugs/drug-alerts-and-statements/fda-alerts-health-care-providers-cases-neurologic-complications-general-anesthesia-linked-genetic fda.gov

RSS Hunter • Jul 2